The Health Home project is evaluating a new program that is part of healthcare reform in New York State. The program identifies individuals with substance use disorders who have other medical and psychiatric problems and offers them a new form of integrated care. The evaluation will study whether this program results in better quality of care and a reduction in health care costs for this vulnerable and chronically ill population.
The Health Home project is evaluating a new program that is part of healthcare reform in New York State. The program identifies individuals with substance use disorders who have other medical and psychiatric problems and offers them a new form of integrated care. The evaluation will study whether this program results in better quality of care and a reduction in health care costs for this vulnerable and chronically ill population.
Antonio Boone presented on PrEP campaigns that have been implemented in the US outside Philadelphia at the February 2016 meeting of the Philadelphia HIV Prevention Planning Group (HPG).
BUILDing Multi-Sector Collaborations to Advance Community HealthPractical Playbook
The Practical Playbook
National Meeting 2016
www.practicalplaybook.org
Bringing Public Health and Primary Care Together: The Practical Playbook National Meeting was at the Hyatt Regency in Bethesda, MD, May 22 - 24, 2016. The meeting was a milestone event towards advancing robust collaborations that improve population health. Key stakeholders from across sectors – representing professional associations, community organizations, government agencies and academic institutions – and across the country came together at the National Meeting to help catalyze a national movement, accelerate collaborations by fostering skill development, and connect with like-minded individuals and organizations to facilitate the exchange of ideas to drive population health improvement.
The National Meeting was also a significant source of tools and resources to advance collaboration. These tools and resources are available below and include:
Session presentations and materials
Poster session content
Photos from the National Meeting
The conversation started at the National Meeting is continuing in a LinkedIn Group "Working Together for Population Health" and Twitter. Use #PPBMeeting to provide feedback on the National Meeting.
The Practical Playbook was developed by the de Beaumont Foundation, the Duke University School of Medicine Department of Community and Family Medicine, the Centers for Disease Control and Prevention (CDC), and the Health Resources & Services Administration (HRSA).
Tackling Post-Ebola Health Recovery: Strengthening health system capacity to ...JSI
In late 2015, the government-mandated Comprehensive Program for Ebola Survivors (CPES) was established as part of the key interventions within the Post-Ebola
Recovery Strategy. The CPES program, sought to improve the well-being of Ebola virus disease (EVD) survivors by providing basic and specialized health care and support to recover their livelihood. Survivors were also included in the existing Free Health Care Initiative (FHCI) program, already offered to children under 5 and pregnant and lactating women. This decision aimed at allowing survivors to access the public-sector health
services without cost.
As the program developed, the MoHS recognized that many of the health issues facing EVD survivors, such as mental health, eye complications, etc. were also common for general population, as well as other FHCI vulnerable population groups. Changes were made to promote self-reliance and were needed to enable the integration of the CPES supported health services and human resources within the MoHS system and the EVD survivors within the FHCI.
The CPES program worked to respond to survivor needs and restore EVD survivors’confidence in a country health system that was heavily disrupted by the Ebola outbreak; and ensure their special needs were addressed in a timely and efficient manner. 10% more survivors were able to lead a healthy functional life because of the project intervention. Moreover, there has been a 6.1% reduction in the proportion of survivors reporting some sort of stigma and a 12% drop in the proportion of those reporting stigma during their last interaction with a healthcare provider. Community support: The peer-to-peer approach implemented with the Survivor Advocates has helped reduce stigma associated with EVD and supported the rebuilding of trust between survivors, the communities, and local health facilities. However, when SAs were terminated, the transition to CHWs had not taken place.
This poster was presented at the Fifth Global Symposium on Health Systems Research in Liverpool in October by Soumya Alva.
Unstable Ground? Comparing Income, Poverty & Health Insurance Estimates from ...soder145
Michael Davern's presentation at the 2009 AcademyHealth Annual Research Meeting, "Unstable Ground? Comparing Income, Poverty & Health Insurance Estimates from Major National Surveys." June 29, 2009, Chicago IL.
This workshop is designed to talk about the impact of STDs on youth under the age of 25. This workshop will discuss the importance of sexual health screenings, partner management, and current data around STD morbidity rates. We will also talk about current STD clinical recommendations for the treatment of gonorrhea, chlamydia, and syphilis. Participants will engage in an interactive activity where they will sharpen their skills on effective partner management strategies.
Evidence on Improving Health Service Delivery in Developing CountriesIDS
This presentation by David Peters of the Future Health Systems Consortium was given at the Global Symposium on Health Systems Research in November 2010.
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorJefferson Center
To generate new, patient-centered insights into diagnostic error, we convened diverse groups in public deliberation to recommend and evaluate actions that patients and/or their advocates would be willing and able to perform to improve diagnostic quality.
Antonio Boone presented on PrEP campaigns that have been implemented in the US outside Philadelphia at the February 2016 meeting of the Philadelphia HIV Prevention Planning Group (HPG).
BUILDing Multi-Sector Collaborations to Advance Community HealthPractical Playbook
The Practical Playbook
National Meeting 2016
www.practicalplaybook.org
Bringing Public Health and Primary Care Together: The Practical Playbook National Meeting was at the Hyatt Regency in Bethesda, MD, May 22 - 24, 2016. The meeting was a milestone event towards advancing robust collaborations that improve population health. Key stakeholders from across sectors – representing professional associations, community organizations, government agencies and academic institutions – and across the country came together at the National Meeting to help catalyze a national movement, accelerate collaborations by fostering skill development, and connect with like-minded individuals and organizations to facilitate the exchange of ideas to drive population health improvement.
The National Meeting was also a significant source of tools and resources to advance collaboration. These tools and resources are available below and include:
Session presentations and materials
Poster session content
Photos from the National Meeting
The conversation started at the National Meeting is continuing in a LinkedIn Group "Working Together for Population Health" and Twitter. Use #PPBMeeting to provide feedback on the National Meeting.
The Practical Playbook was developed by the de Beaumont Foundation, the Duke University School of Medicine Department of Community and Family Medicine, the Centers for Disease Control and Prevention (CDC), and the Health Resources & Services Administration (HRSA).
Tackling Post-Ebola Health Recovery: Strengthening health system capacity to ...JSI
In late 2015, the government-mandated Comprehensive Program for Ebola Survivors (CPES) was established as part of the key interventions within the Post-Ebola
Recovery Strategy. The CPES program, sought to improve the well-being of Ebola virus disease (EVD) survivors by providing basic and specialized health care and support to recover their livelihood. Survivors were also included in the existing Free Health Care Initiative (FHCI) program, already offered to children under 5 and pregnant and lactating women. This decision aimed at allowing survivors to access the public-sector health
services without cost.
As the program developed, the MoHS recognized that many of the health issues facing EVD survivors, such as mental health, eye complications, etc. were also common for general population, as well as other FHCI vulnerable population groups. Changes were made to promote self-reliance and were needed to enable the integration of the CPES supported health services and human resources within the MoHS system and the EVD survivors within the FHCI.
The CPES program worked to respond to survivor needs and restore EVD survivors’confidence in a country health system that was heavily disrupted by the Ebola outbreak; and ensure their special needs were addressed in a timely and efficient manner. 10% more survivors were able to lead a healthy functional life because of the project intervention. Moreover, there has been a 6.1% reduction in the proportion of survivors reporting some sort of stigma and a 12% drop in the proportion of those reporting stigma during their last interaction with a healthcare provider. Community support: The peer-to-peer approach implemented with the Survivor Advocates has helped reduce stigma associated with EVD and supported the rebuilding of trust between survivors, the communities, and local health facilities. However, when SAs were terminated, the transition to CHWs had not taken place.
This poster was presented at the Fifth Global Symposium on Health Systems Research in Liverpool in October by Soumya Alva.
Unstable Ground? Comparing Income, Poverty & Health Insurance Estimates from ...soder145
Michael Davern's presentation at the 2009 AcademyHealth Annual Research Meeting, "Unstable Ground? Comparing Income, Poverty & Health Insurance Estimates from Major National Surveys." June 29, 2009, Chicago IL.
This workshop is designed to talk about the impact of STDs on youth under the age of 25. This workshop will discuss the importance of sexual health screenings, partner management, and current data around STD morbidity rates. We will also talk about current STD clinical recommendations for the treatment of gonorrhea, chlamydia, and syphilis. Participants will engage in an interactive activity where they will sharpen their skills on effective partner management strategies.
Evidence on Improving Health Service Delivery in Developing CountriesIDS
This presentation by David Peters of the Future Health Systems Consortium was given at the Global Symposium on Health Systems Research in November 2010.
Clearing the Error: Patient Participation in Reducing Diagnostic ErrorJefferson Center
To generate new, patient-centered insights into diagnostic error, we convened diverse groups in public deliberation to recommend and evaluate actions that patients and/or their advocates would be willing and able to perform to improve diagnostic quality.
Global Medical Cures™ | HIV TESTING IN USA
DISCLAIMER-
Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
Marketing proposal to Hartford HealthcareArchit Patel
The presentation is a brief description to the proposed marketing strategy for the Hartford healthcare specifically targeting on the New Health Enhancement Program proposed for Connecticut state employees.
The National HIV Prevention Inventory provides the first, comprehensive inventory of HIV prevention efforts at the state and local levels in the United States. Based on a survey of 65 health departments, including all state and territorial jurisdictions and six U.S. cities, the Inventory is intended to offer a baseline picture of how HIV prevention is delivered across the country in an effort to provide policymakers, public health officials, community organizations, and others with a more in depth understanding of HIV prevention and the role played by health departments in its delivery.
The National HIV Prevention Inventory provides the first, comprehensive inventory of HIV prevention efforts at the state and local levels in the United States. Based on a survey of 65 health departments, including all state and territorial jurisdictions and six U.S. cities, the Inventory is intended to offer a baseline picture of how HIV prevention is delivered across the country in an effort to provide policymakers, public health officials, community organizations, and others with a more in depth understanding of HIV prevention and the role played by health departments in its delivery.
Running Head Colorectal Cancer Prevention Program-Evaluation Des.docxaryan532920
Running Head: Colorectal Cancer Prevention Program-Evaluation Design 9
Colorectal Cancer Prevention Program Evaluation Design
Kaplan University-PU630-Unit 7
September 20, 2016
Deserie Thomas
Dr. Amy Thompson
COLORECTAL CANCER PREVENTION PROGRAM EVALUATION DESIGN
Engaged Stakeholders What Stakeholders Want to Know
Public Health Department
Document the resources that have been leveraged to support colorectal cancer prevention program efforts.
Local Legislators
Identify the number of people receiving services and the extent to which interventions are yielding intended awareness, behavioral and/or health outcomes for participants.
Intervention participants
Determine the extent to which interventions are yielding intended awareness, behavioral and/or health outcomes for participants.
Community Clinic
Review the quality, contributions, and impact of the Colorectal Cancer Coalition.
Review the quality and implementation progress of the statewide Colorectal Cancer Coalition plan.
Determine to what extent interventions outlined in the Colorectal Cancer Coalition action plan are being executed and yielding intended results.
Local American Cancer Society Partner
Determine whether American Cancer Society products are being incorporated effectively into the efforts of the colorectal cancer prevention program.
Engaging Stakeholders
Health Department
Members of the evaluation advisory committee
Presenters/advocates who share findings with state and community partners
All phases of the evaluation process via regular evaluation advisory committee meetings
Legislators
External reviewers of evaluation plans and methods
Evaluation planning phase
Intervention Participants
Members of the evaluation advisory committee
Data sources (i.e., participants in evaluation interviews and surveys)
Two representatives to participate in all phases of the evaluation process via regular evaluation advisory committee
Community Clinic
External reviewers of evaluation plans and methods
Evaluation implementation phase
Evaluation planning phase
Local American Cancer Society Partner
Data analysts Presenters/advocates who share findings with state and community partners
Evaluation implementation phase Dissemination phase
Evaluation Stakeholder Group Composition
The composition of the evaluation stakeholders will fund and authorized the continuation or expansion of the Colorectal Cancer Prevention Program. The stakeholders are responsible for day to day implementation of the activities that are part of the program, and has a strong influence on the development of thoughtful evaluation questions that will generate evaluation findings that are useful, relevant, and credible (assuming the evaluation applies the appropriate design and data collection and analysis methods). Ideally, the evaluation stakeholders gro ...
Budget RESEARCHBudget Template - page 1 of 2GRANT(For Internal Use.docxAASTHA76
Budget RESEARCHBudget Template - page 1 of 2GRANT(For Internal Use Only - see specific sponsoringTitle:Union County of Georgia cancer prevention programagency for the proper forms)Date:12-May-17RFA no.PI:Project Period:2017/2018Budget Period:2017-2018Year 1Field researchResearch assitants( Salaries & benefits)250,000Transport120,000Research tools( questionaires and interviews)50,000420,000Screening actvitiesLocal hospital staff service fees80,000Electricity consumed by equipment20,000Maintenace expenses40,000140,000MarketingNutrionists service fees150,000Local gym service15,000Formation of chamber fo commerce180,000Education workshops ( schools and community centers)50,000395,000
pasterme:
rate as of 7/1/05
subject to change
confirm with the SPH
Business Office
pasterme:
part-time student rate as of 7/1/04 subject to change confirm with the SPH Business Office
pasterme:
rate subject to change Please review all budgets with the SPH
Business Office.
Running head: COMMUNITY COALITION 1
COMMUNITY COALITION 3
Community Coalition
Kimberly Crawford
Kaplan University
January 8, 2018
Community Coalition
1. Choose 5 partnerships to engage and explain why you would invite each of these people//organizations to be a part of the coalition.
The creation of community health promotion and education programs takes into consideration several agencies or parties who help in the achievement of the desired health goals. Each of the partners will address its roles using different approaches depending on their area of expertise. This is an important factor to consider as different institutions address health promotion using different approaches and perspectives. The overall outcome from the contribution of every partner should be able to restore and promote the physical, emotional, spiritual, psychological, and social wellness of the community in relation to the health issue being suffered (Minelli, & Breckon, 2009). Chronic diseases are currently the leading causes of death in the community due to their complexity and the severe effects on human health. The community health promotion and education program will be provided by the ‘Health Concerns Coalition’ which will be made up of the following partners; community religious groups, Cancer Supportive Care Foundation, an association of cancer-survivor patients, nutritional organizations, and the local authority.
1. Cancer Supportive Care Foundation – This is an important part of the coalition as it will offer technical expertise in education and diagnosis of chronic diseases. The foundation team will include medical experts who will diagnose the community members of any chronic illnesses. Examinations for diseases such as breast cancer, prostate cancer, diabetes and blood pressure will be conducted by this partner as they will provide modern machines needed for the diagnosis of chronic illnesses.
2. Community religious groups – Community religious groups ca ...
Navigate 2 Scenario for Health PolicyEpisode 1Policy An.docxmayank272369
Navigate 2 Scenario for Health Policy
Episode 1:
Policy Analysis and Development
Overview
In this episode, you will be in a health care policy internship program in a Senator’s office in Washington, D.C. The Senator wants to develop policy that requires all health care organizations that receive federal funds to implement the recommendations presented in the Institute of Medicine reports on quality care. You will develop a policy, so that it can become proposed legislation. You must collect data, describe the problem, solutions and related ethical issues, examine the cost-benefit analysis, identify stakeholders (such as lobbyists from American Hospital Association, health care providers, health care corporations, pharmaceuticals, insurers, etc.), and impact. Based on this information, you will create a policy description that will be the foundation for a bill. You will describe critical issues that would be in the bill such as requirements of hospitals to:
Monitor and report medical errors to the Department of Health and Human Services
Use root cause analysis on a certain percentage of errors
Track and report patient outcomes focused on the clinical problems identified in the
National Health Care
Quality Report
Integrate the 5 health care profession core competencies into staff education and track outcomes
Establish a no-blame culture
*I suggest for you to do some research on your own, and if you use outside sources to help your compile your policy description, be sure to reference them (following an APA format) at the end of your post.
Assignment
You will post a policy description to this discussion board forum. Make sure to identify a plan that addresses legal and ethical issues in a health care policy. You must also respond to 2 of your peers' posts and make sure to reference any outside sources you may have used in your recommendation.
Below are the characters from this LearnScapes scenario (LearnScapes for
Health Policy
1):
The Student (which is you), Health Care Policy Intern for Congress
The student used to work within the Bright Road Health Care System, and had a special interest in policy. The student is thinking about moving into politics, hoping to make a difference at that level. The student has just been accepted into the internship; this is the student’s first big project.
Peter Shackley, Senior Policy Staff Member
The student’s mentor, Peter, is a young and feisty staff member. In his late 20s, Pete has been interested in politics since he was President of his high school student body. He’s especially passionate about policy-making and how the process works. Pete will help guide the student through the policy-making process.
Gretchen Wilde, Senator Chief of Staff
Gretchen is in her 30s and has been the Senator’s Chief of Staff for about 2 years now. She’s very professional, and holds high expectations for everyone in the Senator’s office, including interns. Gretchen is responsible for reviewing polic.
Working with Regulators: A Focus on CMS | Took Kit: A Guide for Patient AdocatesCancerSupportComm
The Affordable Care Act (ACA) is the tip of a very large, multi-faceted iceberg, one that is moving inexorably forward and will result in broad, deep changes in the way that health care in this country is understood and delivered. These changes are already exerting a significant impact on cancer research and care, and will continue to do so for the foreseeable future. This is also an era in which the patient voice and genuine, active patient participation have become integral to the process of developing and implementing biomedical research and health care policy.
That process is complex and multidimensional—but also well defined and transparent. The ability to influence the outcomes requires that an organization have a working knowledge of how the process works, which agencies are responsible and who makes the decisions. It is also critical to understand the ways in which electoral politics at both the national and state level impact health care policy. While that sounds straightforward, the regulatory process often can appear impenetrable to the organizations who seek to make their voices heard and influence the outcomes.
This Tool Kit is intended as a practical guide for patient advocacy organizations in their efforts to educate themselves about the regulatory process, develop appropriate staff expertise and responsibility for this area, and ultimately make a difference.
Keynote address by Dr. Eric Goosby of UCSF, presented at CFAR HIV Research in International Settings (CHRIS) meeting in San Diego, October 1, 2014. Dr. Goosby discussed. "Global Health Delivery and Diplomacy: The Long Road to Sustainable Programs."
Evidence & Implementation of Strategies to Strengthen Health ServicesIDS
This presentation was given by Peters to the International Health Economics Association Conference 2009 in Beijing. It is research conducted as part of the Future Health Systems Research Programme Consortium www.futurehealthsystems.org.
Similar to John Douglas: Chlamydia Prevention in the US - Update from CDC (20)
Presented by Carol Roye, EdD, CPNP, RN, Professor of Nursing, Assistant Dean for Research, Hunter College School of Nursing at the 2013 National Chlamydia Coalition Meeting
A brief update on the National Chlamydia Coalition by Ashley Coffield, MPA, Senior Fellow, Partnership for Prevention. Presented at the 2012 National Chlamydia Coalition meeting.
Presented by Michael Horberg, MD, MAS, FACP, FIDSA,
Executive Director Research, Mid-Atlantic Permanente Medical Group, Director, HIV/AIDS Kaiser Permanente, at the 2012 National Chlamydia Coalition meeting.
Presented by Richard Crosby, PhD, DDI Endowed Professor and Chair, Department of Health Behavior, University of Kentucky at the 2012 National Chlamydia Coalition meeting.
Presented by Marc Garufi, Chief, Public Health Branch, Office of Management and Budget (OMB), Executive Office of the President at the 2012 National Chlamydia Coalition meeting.
Presented by Jo Valentine, MSW, Associate Director, Office of Health Equity, Division of STD Prevention, CDC, at the 2012 National Chlamydia Coalition meeting
A brief update on the National Chlamydia Coalition by Ashley Coffield, MPA, Senior Fellow, Partnership for Prevention. Presented at the 2012 National Chlamydia Coalition meeting.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
John Douglas: Chlamydia Prevention in the US - Update from CDC
1.
2.
3.
4.
5.
6. Chlamydia — Rates: Total and by sex: United States, 1989–2008 Note: As of January 2000, all 50 states and the District of Columbia had regulations requiring the reporting of chlamydia cases. Total Cases =1,210,523 B:W ratio= 8:1 % dx’d STD clinics= 15%
7. Chlamydia — Median state-specific positivity among 15- to 24-year-old women tested in family planning clinics: United States, 1997–2008 Note: As of 1997, all 10 DHHS regions, representing all 50 states, the District of Columbia, and outlying areas, reported chlamydia positivity data. SOURCE: Prevalence Monitoring Project (Regional Infertility Prevention Projects); Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention
8.
9. Annual Chlamydia Screening in Commercial and Medicaid Plans, HEDIS 2000 - 2008 Data from State of Health Care Quality reports from NCQA,, Healthcare Effectiveness Data and Information Set. 59% 53% 43% 40%
10.
11.
12.
13.
14.
15. Tuesday, December 1, 2009 WETZSTEIN: STD exams needed early A prominent medical group recently suggested that American teenage girls and college-age women avoid getting gynecological exams for cervical cancer until they turn 21. I hate to second-guess this esteemed group, but when one in four U.S. teenage girls has a sexually transmitted disease (STD), the advice seems odd to me. I would think medical professionals would urge every American woman who is single and sexually active to run, not walk, to a doctor's office every few months for a genital checkup. This goes double for teens and college-age girls. Getting regular genital exams is just prudent these days - and with chlamydia cases reported at a record 1.2 million, there's no time to delay. Chlamydia is curable with antibiotics, said Susan Maloney of the National Chlamydia Coalition. The chlamydia test is easy to do (just a vaginal swab); some doctors are starting to ask women getting Pap smears whether they would like a chlamydia test too. Sexually active young women should ask their doctors for a chlamydia test whether they "feel anything or not," Ms. Maloney said.
16.
17.
18. Evolving Landscape of EPT: Legal Status Summary EPT is Potentially Allowable EPT is Likely Prohibited EPT is Permissible Legislation Pending 2006—2009: Increase of 10 states Non-EPT states with >30 k reported cases: --FL, OH, MI, GA, NC, VA --23% all reported CT CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD ( Baltimore only) CA OR WA NV NM UT AZ WY CO NB KS MO AR OK FL GA AL MS LA TX WI IA MN ID MT ND SD NC VA WV KY TN OH MI IN IL VT AK HI ME NY PA RI MA NJ CT NH SC DE DC MD 2006 2009